[Comparative study of two microbiological assay methods of serum isoniazid]. 1982

E Borderon, and B Hamel, and J C Borderon, and M Jamet, and G Calamy

Two microbiological assay techniques for estimation of biologically active isoniazid concentrations in human serum were compared : the vertical diffusion method and a large plate method similar to that commonly used for the antibiotics. Four hundred seventy four tests were carried out on the serum from 133 patients. Parallel titrations were determined by two biologists on the same serum samples, with the same standard solutions, by the two methods performed rapidly after the collection of specimens and after they have been stored in the frozen state during one week and were compared. It was found that the variability obtained in these conditions was 26 per cent for the vertical diffusion method and 14 per cent for the large plate method. The correlation coefficients were 0,87 and 0,95 respectively. Also it will be noted that the large plate method is faster, of lower cost and require smaller volumes of serum. However, it also failed to detect levels lower than 0,5 and upper than 2 micrograms/ml, the standard curve is not stable and must be run with each assay and it is also subject to interference by other antibiotics.

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

E Borderon, and B Hamel, and J C Borderon, and M Jamet, and G Calamy
January 1984, Revue de pneumologie clinique,
E Borderon, and B Hamel, and J C Borderon, and M Jamet, and G Calamy
January 1971, Revue de tuberculose et de pneumologie,
E Borderon, and B Hamel, and J C Borderon, and M Jamet, and G Calamy
February 1954, Polski tygodnik lekarski,
E Borderon, and B Hamel, and J C Borderon, and M Jamet, and G Calamy
January 2009, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
E Borderon, and B Hamel, and J C Borderon, and M Jamet, and G Calamy
April 1960, Revue de tuberculose et de pneumologie,
E Borderon, and B Hamel, and J C Borderon, and M Jamet, and G Calamy
July 1981, The veterinary quarterly,
E Borderon, and B Hamel, and J C Borderon, and M Jamet, and G Calamy
January 1962, Advances in clinical chemistry,
E Borderon, and B Hamel, and J C Borderon, and M Jamet, and G Calamy
January 1977, Scandinavian journal of infectious diseases,
E Borderon, and B Hamel, and J C Borderon, and M Jamet, and G Calamy
November 1964, Journal of clinical pathology,
E Borderon, and B Hamel, and J C Borderon, and M Jamet, and G Calamy
January 1984, Scandinavian journal of infectious diseases,
Copied contents to your clipboard!